The CLARITY Juvenile Arthritis Research Platform
It is estimated that around 100 children develop juvenile arthritis each year in Victoria. This condition affects a child’s joints and other parts of the body, causing pain, swelling, stiffness, difficulty moving and sometimes even fevers and rashes.
With support from the Good Friday Appeal, The Royal Children’s Hospital (RCH) Department of Rheumatology has established the CLARITY Juvenile Arthritis Research Platform to better understand and treat the disease.
The RCH and the Murdoch Children’s Research Institute are home to Australia’s only paediatric rheumatology research program, and the new CLARITY study is set to help translate research findings into practice, improving clinical care for children both locally, nationally and internationally. With the aim of enrolling 250 participants annually, the study will enable new research that aims to identify biomarkers for diagnosis, prognosis and treatment of children with juvenile arthritis.
Photo: RCH Melbourne – Creative Studio Photography
Posted June 2018